
News|Articles|June 11, 2013
Aceto to launch generic for ALS treatment
Aceto Corporation, Port Washington, N.Y., announced June 11 that its generics subsidiary, Rising Pharmaceuticals Inc., Paramus, N.J., will launch the 50-mg strength of riluzole tablets.
Advertisement
Aceto Corporation, Port Washington, N.Y., announced June 11 that its generics subsidiary, Rising Pharmaceuticals Inc., Paramus, N.J., will launch the 50-mg strength of riluzole tablets.
Riluzole is used to treat amyotrophic lateral sclerosis (ALS) and in 2012 generated $64 million in sales, according to IMS Health. Aceto’s product is an FDA-approved version of Covis Pharma's (Switzerland) Rilutek. Rising Pharmaceuticals has launched nine generic products in 2013.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Zepbound Lowers Health Care Costs in Older Adults With Obesity
2
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
3
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
4
How mRNA and Protein-Based COVID-19 Vaccines Work
5






































